51
|
Nijs J, Loggia ML, Polli A, Moens M, Huysmans E, Goudman L, Meeus M, Vanderweeën L, Ickmans K, Clauw D. Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients? Expert Opin Ther Targets 2017; 21:817-826. [DOI: 10.1080/14728222.2017.1353603] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Jo Nijs
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physical Medicine and Physiotherapy, University Hospital Brussels, Brussels, Belgium
| | - Marco L. Loggia
- MGH/HST A. A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
| | - Andrea Polli
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium
| | - Maarten Moens
- Department of Neurosurgery and Radiology, University Hospital Brussels, Brussels, Belgium
- Department of Manual Therapy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium
| | - Eva Huysmans
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium
| | - Lisa Goudman
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Neurosurgery and Radiology, University Hospital Brussels, Brussels, Belgium
| | - Mira Meeus
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium
- Department of Rehabilitation Sciences and Physiotherapy, University of Antwerp, Antwerp, Belgium
| | - Luc Vanderweeën
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium
- Private Practice for Spinal Manual Therapy, Schepdaal-Dilbeek, Belgium
| | - Kelly Ickmans
- Department of physiotherapy, human physiology and anatomy, Pain in Motion International Research Group, Vrije Universiteit Brussel, Brussels, Belgium
- Department of Physical Medicine and Physiotherapy, University Hospital Brussels, Brussels, Belgium
| | - Daniel Clauw
- Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, USA
| |
Collapse
|
70
|
Zarpelon AC, Rodrigues FC, Lopes AH, Souza GR, Carvalho TT, Pinto LG, Xu D, Ferreira SH, Alves-Filho JC, McInnes IB, Ryffel B, Quesniaux VFJ, Reverchon F, Mortaud S, Menuet A, Liew FY, Cunha FQ, Cunha TM, Verri WA. Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB J 2015; 30:54-65. [PMID: 26310268 DOI: 10.1096/fj.14-267146] [Citation(s) in RCA: 110] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2015] [Accepted: 08/13/2015] [Indexed: 12/30/2022]
Abstract
Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL-33/IL-33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL-33 production in the spinal cord. IL-33/citrine reporter mice revealed that oligodendrocytes are the main cells expressing IL-33 within the spinal cord together with a minor expression by neurons, microglia. and astrocytes. CCI-induced mechanical hyperalgesia was reduced in IL-33R (ST2)(-/ -) mice compared with wild-type (WT) mice. Intrathecal treatment of WT mice with soluble IL-33 receptor (IL-33 decoy receptor) markedly reduced CCI-induced hyperalgesia. Consistent with these observations, intrathecal injection of IL-33 enhanced CCI hyperalgesia and induced hyperalgesia in naive mice. IL-33-mediated hyperalgesia during CCI was dependent on a reciprocal relationship with TNF-α and IL-1β. IL-33-induced hyperalgesia was markedly attenuated by inhibitors of PI3K, mammalian target of rapamycin, MAPKs (p38, ERK, and JNK), NF-κB, and also by the inhibitors of glial cells (microglia and astrocytes). Furthermore, targeting these signaling pathways and cells inhibited IL-33-induced TNF-α and IL-1β production in the spinal cord. Our study, therefore, reveals an important role of oligodendrocyte-derived IL-33 in neuropathic pain.
Collapse
Affiliation(s)
- Ana C Zarpelon
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Francielle C Rodrigues
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Alexandre H Lopes
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Guilherme R Souza
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Thacyana T Carvalho
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Larissa G Pinto
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Damo Xu
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Sergio H Ferreira
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Jose C Alves-Filho
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Iain B McInnes
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Bernhard Ryffel
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Valérie F J Quesniaux
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Flora Reverchon
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Stéphane Mortaud
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Arnaud Menuet
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Foo Y Liew
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Fernando Q Cunha
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Thiago M Cunha
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| | - Waldiceu A Verri
- *Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Parana, Brazil; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, United Kingdom; Unités Mixtes de Recherche 7355, Centre National de la Recherche Scientifique Experimental and Molecular Immunology and Neurogenetics, Orléans, France; Immunologie et Neurogénétique Expérimentales et Moléculaires, University of Orléans, Orléans, France; and School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China
| |
Collapse
|